الفهرس 
Effect of Light Therapy on Postmenopausal Osteoporosis
AbstractOnly 14 pages are availabe for public view
 |  | from | 150 |  |  |
| | | from | 150 | | |
Abstract
Background: Postmenopausal osteoporosis, a major public health problem worldwide, is associated with low quality of life, high morbidity and mortality rates, and huge socio-economic burden. Purpose: This study aimed to investigate the effect of bioptron light therapy on postmenopausal osteoporosis. Subjects: Thirty postmenopausal women with hip osteoporosis, aged 50-60 years, with BMI of 25-32 kg/m2, were randomized into two groups equal in number. group (A) received medical treatment in the form of calcium, vitamin D3 and sodium fluoride supplementation for 4 weeks (n=15), while group (B) received the same medical treatment in addition to bioptron light therapy for 4 weeks (n=15). Material and Method: The bone mineral density (BMD) was assessed through measuring the total hip T{u2013}score, while the quality of life was assessed through calculating the total score of Quality of Life Questionnaire of the European Foundation for Osteoporosis (QUALEFFO-41) were evaluated pre- and post-treatment. Results: Comparing both groups pre- and post-treatment revealed that there was a statistically non-significant difference in total hip T{u2013}score (P>0.05). Also, total score of QUALEFFO-41 revealed astatistically non-significant difference pre-treatment (P>0.05), while post-treatment, it revealed a statistically significant reduction (P<0.05) in favour of group (B). The percentages of improvement post-treatment in total hip T{u2013}score and total score of QUALEFFO-41 were 2.4% and 15.65% in group (A), while they were 11.29% and 31.63% in group (B). Conclusion: Bioptron light therapy is effective in treating postmenopausal women with hip osteoporosis through producing a greater improvement percentage in total hip BMD and improving their quality of life